Our functional and structural data, along with molecular dynamics (MD) simulations, suggest that receptor conformational dynamics associated with flexibility of the peptide N-terminal activation domain may be a key determinant of agonist efficacy
Specifically, gastroparesis is characterized by the stomachs inability to move food effectively through the digestive tract
The underreported symptoms are leads that came from patients themselves, unprompted, and clinicians could potentially pay attention to them. Clinical trials generally identify the most dangerous side effects of drugs, adds Lyle Ungar, Professor in CIS and a co-author on the study
This can affect the digestion and absorption of dietary fats and fat-soluble vitamins (A, D, E, K), but does not impact the injectable medication itself
Although several studies have indicated that the novel antidiabetic drugs, including sodium glucose cotransporter 2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP-1 RA) and dipeptidyl peptidase 4 inhibitors (DPP4i) provide the cardiovascular benefits in T2DM patients with HFpEF, the elaborated roles and mechanisms are not fully understood
